Platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive impairment

被引:47
|
作者
Gattaz, WF
Forlenza, OV
Talib, LL
Barbosa, NR
Bottino, CMC
机构
[1] Univ Sao Paulo, Fac Med, Dept Psychiat, Neurosci Lab, BR-05403010 Sao Paulo, Brazil
[2] Univ Sao Paulo, Fac Med, Inst Psychiat, Old Age Res Grp PROTER, BR-05403010 Sao Paulo, Brazil
关键词
dementia; Alzheimer's disease; mild cognitive impairment; brain phospholipids; phospholipase A(2); PLA(2); platelets;
D O I
10.1007/s00702-004-0142-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Phospholipase A(2) (PLA(2)) controls the metabolism of phospholipids in cell membranes. In the brain, PLA(2) influences the processing of the amyloid precursor protein (APP) and thus the production of the amyloid-beta peptides (Abeta), which are the major components of the senile plaques in Alzheimer's disease (AD). Reduced PLA(2) activity has been reported in brain and in platelets of AD patients. In the present study we investigated PLA(2) activity in platelets from 21 AD patients as compared to 17 healthy elderly controls and 11 individuals with mild cognitive impairment (MCI). Subjects were cognitively assessed by the Mini-Mental State Examination (MMSE) and the CAMDEX schedule. Platelet PLA(2) activity was determined by radio-enzymatic assay, which mainly detected a calcium-independent form of the enzyme present also in the brain (iPLA(2)). PLA(2) activity was significantly lower in AD than in controls (p < 0.001). Mean PLA(2) activity in MCI individuals was between the values of AD patients and controls, with a subgroup showing PLA as low as the lowest AD patients, but the differences from MCI were not significant from AD and control groups. Lower PLA(2) activity was significantly correlated with a worse cognitive performance both at the MMSE (p = 0.001) and the cognitive sub-scale of the CAMDEX inventory (p = 0.002). Our data replicate previous findings of reduced platelet PLA(2) activity in AD. Both reduced PLA(2) activity and the correlation with impaired cognition were also reported in brain tissue of AD patients, suggesting thus that the present determinations in platelets may be related to a reduction in the brain. In the brain the inhibition of PLA(2) inhibits the physiological secretion of the APP, a mechanism that increases Abeta formation. Further longitudinal studies should investigate whether those MCI individuals with the lowest PLA(2) values in platelets would be at a higher risk to develop AD during a longitudinal follow up.
引用
收藏
页码:591 / 601
页数:11
相关论文
共 50 条
  • [31] Metalloproteinase’s Activity and Oxidative Stress in Mild Cognitive Impairment and Alzheimer’s Disease
    Sagrario Martín-Aragón
    Paloma Bermejo-Bescós
    Juana Benedí
    Emanuela Felici
    Pedro Gil
    José Manuel Ribera
    Ángel Ma Villar
    Neurochemical Research, 2009, 34
  • [32] MRI in Alzheimer's disease and mild cognitive impairment
    Jack, CR
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 4S - 4S
  • [33] Galantamine for Alzheimer's disease and mild cognitive impairment
    Loy, C
    Schneider, L
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (01):
  • [34] Neuropathology of Alzheimer's disease and mild cognitive impairment
    López, OL
    DeKosky, ST
    REVISTA DE NEUROLOGIA, 2003, 37 (02) : 155 - 163
  • [35] Taste in mild cognitive impairment and Alzheimer's disease
    Steinbach, Silke
    Hundt, Walter
    Vaitl, Andreas
    Heinrich, Petra
    Foerster, Stefan
    Buerger, Katharina
    Zahnert, Thomas
    JOURNAL OF NEUROLOGY, 2010, 257 (02) : 238 - 246
  • [36] Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study
    Davidson, Julie E.
    Lockhart, Andrew
    Amos, Leslie
    Stirnadel-Farrant, Heide A.
    Mooser, Vincent
    Sollberger, Marc
    Regeniter, Axel
    Monsch, Andreas U.
    Irizarry, Michael C.
    ALZHEIMERS RESEARCH & THERAPY, 2012, 4 (06):
  • [37] Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study
    Julie E Davidson
    Andrew Lockhart
    Leslie Amos
    Heide A Stirnadel-Farrant
    Vincent Mooser
    Marc Sollberger
    Axel Regeniter
    Andreas U Monsch
    Michael C Irizarry
    Alzheimer's Research & Therapy, 4
  • [38] Biomarkers of mild cognitive impairment and Alzheimer's disease
    Tang, Bor Luen
    Kumar, Rajeev
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2008, 37 (05) : 406 - 410
  • [39] Taste in mild cognitive impairment and Alzheimer’s disease
    Silke Steinbach
    Walter Hundt
    Andreas Vaitl
    Petra Heinrich
    Stefan Förster
    Katharina Bürger
    Thomas Zahnert
    Journal of Neurology, 2010, 257 : 238 - 246
  • [40] Mild cognitive impairment: Aging to Alzheimer's disease
    Bieber, MR
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (10): : 1897 - 1898